MEDIPAL HOLDINGS CORPORATIONJP:7459

Market cap
¥565.3B
P/E ratio
26.8x
Mar 31,
2013
Mar 31,
2014
Mar 31,
2015
Mar 31,
2016
Mar 31,
2017
Mar 31,
2018
Mar 31,
2019
Mar 31,
2020
Mar 31,
2021
Mar 31,
2022
Mar 31,
2023
Mar 31,
2024
Profit (loss) before income taxes39,90248,50244,92354,80652,45363,46663,46175,53649,23757,28470,06174,741
Depreciation12,61813,14712,32512,39113,57314,89813,45214,23214,46814,08314,39316,931
Impairment losses9777052991,2801,06532478861,580100266707
Amortization of goodwill---682214764764553242552551,051
Increase (decrease) in provision for bonuses369496-246713-614141-46855-1,470-209712143
Increase (decrease) in allowance for doubtful accounts41-468-253-52-87-214-71-400-198985-1,553-26
Increase (decrease) in provision for loss on disaster--------363134-497453
Increase (decrease) in provision for loss on Anti-Monopoly Act---------3,4792,225-
Increase (decrease) in retirement benefit liability-18,377-4641,712280-68-201-534-2,772-45-136-435
Interest and dividend income-2,119-1,931-2,305-2,381-3,341-2,471-2,668-2,788-2,846-2,709-2,636-2,791
Interest expenses5134263613453032371801375016348
Share of loss (profit) of entities accounted for using equity method-1,010-4,640-1,086-1,791-1,929-1,531-2,103-3,025-2,439-3,484-3,590-3,584
Loss (gain) on sale and retirement of non-current assets253189-1,154168-577129412-8,913-57231147141
Loss (gain) on step acquisitions------------1,253
Loss (gain) on sale of short-term and long-term investment securities-5,932-7-184-1,374-2-49-166-663-10,450-398-13,044-8,736
Loss (gain) on valuation of short-term and long-term investment securities1053961093079659501,6331,3206,189225
Compensation income-----------66-1,944
Loss on disaster----145-332-13616720259
Decrease (increase) in trade receivables3,660-68,27215,400-17,09712,924-5,10010,901-2,702-12,682-10,283-5,364-23,053
Decrease (increase) in inventories-4,555-9,0529,7064,751-4,3861,59214-5,252-4,284-3,739-2,274-779
Decrease (increase) in retirement benefit asset---2,7753,188-724-958351902-3,1232734-3,031
Increase (decrease) in trade payables13,74957,199-6,488-2,053-4,8143,3222,53613,97616,3907,982-23,34125,269
Increase (decrease) in accrued consumption taxes-3,525-5818,641-8,200-3064,944-3,126178-340280-2,3462,497
Other, net------64-2591,5051,708-3,5363,943
Subtotal65,49432,12779,40338,11766,45772,99783,12382,72655,16066,37136,20180,737
Interest and dividends received2,6732,2283,1813,5274,3193,9704,1294,2485,1064,7084,8505,978
Interest paid-507-423-356-345-303-236-180-137-50-16-34-5
Proceeds from insurance income------200--333497-
Proceeds from compensation-----------2,768
Payments associated with disaster loss-----76--262--29-376-657-249
Payments into deposit money------------3,085
Income taxes paid-5,857-33,638-1,762-19,314-22,442-13,172-23,294-29,919-15,145-9,620-24,709-24,298
Net cash provided by (used in) operating activities61,769-7280,46621,98547,95463,55863,71656,91734,44861,21616,14661,843
Payments into time deposits-8,570-8,676-8,676-8,676-1,576-1,476-1,476-1,476-1,470-1,470-1,470-2,070
Proceeds from withdrawal of time deposits8,6509,1708,6768,6765,1761,4761,4761,4761,4761,4701,4702,070
Purchase of property, plant and equipment-18,696-20,716-10,378-34,392-32,331-25,598-14,579-24,299-12,842-15,958-10,483-15,560
Proceeds from sale of property, plant and equipment1,6904989,1667942,0143,13299914,0301,23125521344
Purchase of intangible assets-2,610-4,027-4,789-4,003-3,506-4,902-3,912-3,053-2,826-2,919-3,021-3,835
Purchase of investment securities-3,359-952-5,582-635-4,062-777-3,271-976-2,133-6,808-799-1,085
Proceeds from sale and redemption of investment securities6,7758021,9213,8318474719102,07414,66088117,83210,556
Purchase of shares of subsidiaries and associates-99-81-2,178-3,141-98-21,449-3,940-1,808-2,122---518
Proceeds from sale of shares of subsidiaries and associates42---35,560---61,000-
Purchase of Investments in other securities of subsidiaries and associates----------813-1,925-340
Purchase of shares of subsidiaries resulting in change in scope of consolidation-----------39,172-
Payments for investments in silent partnerships-----------4,322-610
Loan advances-6-5-36-3-8-9-1-108--3--
Proceeds from collection of loans receivable43405625253216118332
Other, net309745-34541,6754744018441,0786951,1813,531
Net cash provided by (used in) investing activities-15,841-28,065-11,834-41,267-11,354-43,064-23,512-13,319-2,939-24,343-39,494-7,817
Repayments of lease liabilities-744-527-435-427-549-1,542-1,568-1,532-1,374-1,444-1,422-1,312
Proceeds from share issuance to non-controlling shareholders----------20-
Redemption of convertible bond-type bonds with subscription rights to shares-----------30,000-
Proceeds from sale of treasury shares------------
Purchase of treasury shares-8,175-4-2-4-1-2,935-6,060-28,250-2-1-1-10,090
Dividends paid-4,129-4,967-5,426-5,661-6,793-7,221-8,052-8,648-8,818-8,818-9,658-11,179
Dividends paid to non-controlling interests---1,394-1,489-1,711-1,869-2,123-2,186-2,250-2,377-2,479-2,664
Net cash provided by (used in) financing activities-14,379-2,834-19,8346,093-17,66315,845-30,755-49,067-16,003-16,471-43,541-25,248
Effect of exchange rate change on cash and cash equivalents----41-32-9------
Net increase (decrease) in cash and cash equivalents31,549-30,97248,797-13,22918,90436,3299,448-5,47015,50620,403-66,88928,778
Increase in cash and cash equivalents resulting from inclusion of subsidiaries in consolidation-----------5,744